hotspot -WSS

hotspot

author：entertainment 2025-09-28 20:32:54 - browse：9

Astrazeneca office building -- health policy coverage from STAT — AstraZeneca is suing the Biden administration to stop a new Medicare drug price negotiation program. Adobe

WASHINGTON — AstraZeneca is the sixth drugmaker to pile on a legal challenge to the Biden administration’s drug pricing reform law.

The Medicare drug price negotiation program created in the Inflation Reduction Act is set to kick off in the next week, as officials will release the names of the first 10 medicines that will be selected for the program. Medicines are eligible for selection if they are one of the highest-spend drugs for Medicare, and they have no generic competition.

AstraZeneca makes drugs that could be selected for the list, and asked a Delaware district court judge to rule that Medicare acted illegally and that the law is unconstitutional.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Idaho abortion case may prompt more restrictions in other states

Wikipedia

explore

knowledge

WSS

Studies point to risks of excluding people with obesity from drug trials

STAT Readout Newsletter: Today's biggest biotech updates

New Medicare drug pricing powers could soon be upended in court

STAT Summit: GSK CEO on pharma giant's new direction

Hospital price transparency does save money, advocate argues

STAT Readout Newsletter: Today's biggest biotech updates

Wikipedia

hotspot

Wikipedia

BioMarin wins approval for gene therapy to treat hemophilia A

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

New Medicare drug pricing powers could soon be upended in court

In Memoriam: Notable people who died in 2023

GSK to buy asthma

Walensky prepares to leave CDC — and Congress — behind

Why health workers in Gaza are injured or die at high rates

Virginia high school admissions case could be legal follow

Generative AI mines health records to identify patients’ social needs

focus

Pharmacists can make shortage drugs, but at what cost?

The SUPPORT Act is critical to fighting the opioid crisis

NIH confirmation hearing shows politicization of research

Biotech reporter’s notebook: A sunnier mood at JPM 2024

Doulas covered by Medicaid under New York's new plan

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

Wikipedia

explore

knowledge

entertainment